SOX2 and pancreatic neoplasm: In pancreatic cancer, NANOG forms a regulatory network with other transcription factors, such as KLF4 and SOX2, that promotes stem cell maintenance in CSCs and drives gemcitabine resistance through the upregulation of c‐Myc.93